Privacy and Whole Genome Sequencing
With respect to health and
healthcare, it’s thrilling to look forward to a time when cures are found and
people who have banked their genetic code can be contacted to learn about and
benefit from them.
At the same time, many are
concerned about potentially negative consequences of the availability of
genetic information. What if, in the wrong hands, it could affect health
insurance, employment, loans, a divorce or custody case, even the chance of
finding a spouse – not only for the individual but other living and future
relatives?
The Center for Practical
Bioethics’ 2013 Fall Symposium, “Ethical Frontiers in the Brave New World of
Genomics and Learning Health Systems” on November 8 will explore the ethical
implications of whole genome sequencing in light of its rapid growth and
importance to Learning Health Systems, where knowledge is drawn from every encounter, both research and
clinical, yet policies regarding the handling of data differ
substantially.
The Presidential
Commission and Beyond
The Presidential
Commission for the Study of Bioethical Issues’ report submitted to President
Obama in October 2012, “Privacy
and Progress in Whole Genome Sequencing,” made recommendations in six
areas:
·
Strong baseline
protections while promoting data access and sharing
·
Data security and
access to databases
·
Informed consent
process
·
Facilitating progress
in whole genome sequencing
·
Public benefit from
medical advances that result from whole genome sequencing
“The Presidential
Commission’s work and the Center’s Symposium,” said Alan Rubel, JD, PhD, “are
first steps in the process of tailoring the apparatus we already have in place
to deal with the problems inherent in whole genome sequencing.” Dr. Rubel served
as an advisor to the Presidential Commission, an assistant professor at the
University of Wisconsin School of Law, and will join the faculty at the
Symposium.
Procedures to Drive
Benefit & Minimize Risk
“The potential for people
to benefit and suffer negative consequences from whole genome sequencing is
substantial enough that we need to develop procedures to ensure that we derive
the most benefit without jeopardizing people’s well being,” said Dr. Rubel.
“How information is used isn’t always clear. There ought to be some way – some
standard language – to convey what the possibilities are so that people
donating material or having their genome sequenced can be said to properly
consent. There are issues of data security as well.”
Dr. Rubel is a strong
proponent of providing more and better information to the public about what
whole genome sequencing can and cannot do. “Many conditions have to do with
chronic and environmental disease that can be prevented by changes in
lifestyle, independent of genomics, and may be better addressed without getting
into genomics.”
He also believes that
concerns about privacy often mask other worries that may be best understood as
issues of justice. “If, for example, our worry is that genetic information
being disclosed will harm our employment, it may be that the real problem is
how vulnerable people are in terms of employment, and if we deal with that, the
genetic issue goes away.”
About the Symposium
At this Symposium, you
will:
·
Hear updates on
progress in the brave new world of genetic science.
·
Gain insight into
ethical issues around data collection, privacy and informed consent, especially
as they apply to genomics and Learning Health Systems.
·
Explore what type of
ethical framework is needed to advance research while protecting human subjects
in Learning Health Systems.
Register now
at https://www.practicalbioethics.org/register-learning-health-systems.
For more information, contact Cindy Leyland at 816-979-1357 or cleyland@practicalbioethics.org.
Labels: genome sequencing, genomics, learn the health system